{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:38:41Z","timestamp":1790354321321,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is associated with severe systemic complications and increased mortality risk. Predicting SCD severity is currently difficult because of a lack of biomarkers. Here, we measured 5411 plasma proteins in 376 patients with SCD and 103 participants without SCD to find new predictors of SCD mortality. We used protein signatures of mortality that were developed in non-SCD populations to calculate predicted mortality risk scores in our SCD data set. The mortality scores were higher in patients with SCD than in individuals without SCD (P = 3.7 \u00d7 10\u02d710) and were associated with increased mortality in patients with SCD (risk factor\u2013adjusted hazard ratio, 2.2; 95% confidence interval, 1.3-3.6; P = .0032). The mortality scores correlated with several clinical variables (eg, white blood cell count and hemoglobin concentration) and complications (eg, leg ulcers and stroke) that are clinically relevant yet insufficient individually to predict SCD mortality. In addition to the protein signatures, we found 499 plasma proteins that associate with mortality in patients with SCD (false discovery rate of \u22645%), including many proteins involved in inflammatory responses, such as the interleukin-18 signaling cascade. Finally, we estimated biological age in patients with SCD and individuals without SCD using the plasma proteome data. We confirmed that SCD patients age prematurely (+6.0 \u00b1 5.4 years older than their chronological age) and found that brain biological age positively associates with past occurrences of stroke. Altogether, our results support the use of the plasma proteome to monitor and predict clinical severity in SCD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019294","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:41:09Z","timestamp":1773952869000},"page":"3420-3430","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Plasma proteome signatures are predictive of mortality in sickle cell disease"],"prefix":"10.1182","volume":"10","author":[{"given":"Arnaud","family":"Chignon","sequence":"first","affiliation":[{"name":"1Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada"},{"name":"2Montreal Heart Institute, Montr\u00e9al, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosr","family":"Zaouali","sequence":"additional","affiliation":[{"name":"3Red Cell Genetic Disease Unit, H\u00f4pital Henri-Mondor, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris-Est, Mondor Institute for Biomedical Research U955 \u00c9quipe no. 2, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Galact\u00e9ros","sequence":"additional","affiliation":[{"name":"3Red Cell Genetic Disease Unit, H\u00f4pital Henri-Mondor, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris-Est, Mondor Institute for Biomedical Research U955 \u00c9quipe no. 2, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7007-1344","authenticated-orcid":false,"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[{"name":"3Red Cell Genetic Disease Unit, H\u00f4pital Henri-Mondor, Assistance Publique\u2013H\u00f4pitaux de Paris, Universit\u00e9 Paris-Est, Mondor Institute for Biomedical Research U955 \u00c9quipe no. 2, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-3399","authenticated-orcid":false,"given":"Guillaume","family":"Lettre","sequence":"additional","affiliation":[{"name":"1Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada"},{"name":"2Montreal Heart Institute, Montr\u00e9al, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"2026052610365517300_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Disease","year":"2016","journal-title":"Lancet"},{"key":"2026052610365517300_bib2","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"2026052610365517300_bib3","doi-asserted-by":"crossref","first-page":"e1915374","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2026052610365517300_bib4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jamapediatrics.2025.2997","article-title":"Mortality rate trends for sickle cell disease and cystic fibrosis in the US","volume":"179","author":"Abraha","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2026052610365517300_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2011.08961.x","article-title":"Biomarkers in sickle cell disease","volume":"156","author":"Rees","year":"2012","journal-title":"Br J Haematol"},{"issue":"1","key":"2026052610365517300_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13045-022-01237-z","article-title":"Advances in the diagnosis and treatment of sickle cell disease","volume":"15","author":"Brandow","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2026052610365517300_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","article-title":"Emerging genetic therapy for sickle cell disease","volume":"70","author":"Orkin","year":"2019","journal-title":"Annu Rev Med"},{"issue":"33","key":"2026052610365517300_bib8","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"Lettre","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7982","key":"2026052610365517300_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"issue":"7982","key":"2026052610365517300_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"1","key":"2026052610365517300_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cmet.2024.10.005","article-title":"Plasma protein-based organ-specific aging and mortality models unveil diseases as accelerated aging of organismal systems","volume":"37","author":"Goeminne","year":"2025","journal-title":"Cell Metab"},{"issue":"9","key":"2026052610365517300_bib12","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1038\/s41591-024-03164-7","article-title":"Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations","volume":"30","author":"Argentieri","year":"2024","journal-title":"Nat Med"},{"issue":"3","key":"2026052610365517300_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s41591-024-03483-9","article-title":"Integrating the environmental and genetic architectures of aging and mortality","volume":"31","author":"Argentieri","year":"2025","journal-title":"Nat Med"},{"issue":"7990","key":"2026052610365517300_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","article-title":"Organ aging signatures in the plasma proteome track health and disease","volume":"624","author":"Oh","year":"2023","journal-title":"Nature"},{"issue":"12","key":"2026052610365517300_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41576-022-00511-7","article-title":"Measuring biological age using omics data","volume":"23","author":"Rutledge","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"8","key":"2026052610365517300_bib16","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/s41591-025-03798-1","article-title":"Plasma proteomics links brain and immune system aging with healthspan and longevity","volume":"31","author":"Oh","year":"2025","journal-title":"Nat Med"},{"issue":"8","key":"2026052610365517300_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2023.13258","article-title":"Evaluation of large-scale proteomics for prediction of cardiovascular events","volume":"330","author":"Helgason","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"2026052610365517300_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood-2008-03-142604","article-title":"Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease","volume":"113","author":"Yuditskaya","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2026052610365517300_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3324\/haematol.2018.187815","article-title":"Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction","volume":"103","author":"Tewari","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"2026052610365517300_bib20","doi-asserted-by":"crossref","first-page":"e2100003","DOI":"10.1002\/prca.202100003","article-title":"Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease","volume":"15","author":"Lance","year":"2021","journal-title":"Proteomics Clin Appl"},{"issue":"15","key":"2026052610365517300_bib21","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1182\/blood-2012-04-424184","article-title":"Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis","volume":"120","author":"Bartolucci","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2026052610365517300_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/230638","article-title":"Statistical methods for comparing regression coefficients between models","volume":"100","author":"Clogg","year":"1995","journal-title":"Am J Sociol"},{"issue":"7","key":"2026052610365517300_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s43587-024-00655-7","article-title":"Blood protein assessment of leading incident diseases and mortality in the UK Biobank","volume":"4","author":"Gadd","year":"2024","journal-title":"Nat Aging"},{"issue":"8","key":"2026052610365517300_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/hmg\/ddaf015","article-title":"A replication study of novel fetal hemoglobin-associated genetic variants in sickle cell disease-only cohorts","volume":"34","author":"Ilboudo","year":"2025","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2026052610365517300_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.19970","article-title":"Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease","volume":"206","author":"de Ligt","year":"2025","journal-title":"Br J Haematol"},{"issue":"11","key":"2026052610365517300_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2215\/CJN.0000000000000257","article-title":"Differences in the circulating proteome in individuals with versus without sickle cell trait","volume":"18","author":"Cai","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2026052610365517300_bib27","doi-asserted-by":"crossref","first-page":"e70019","DOI":"10.1002\/prca.70019","article-title":"Targeted proteomic analysis of sickle cell disease patients with elevated tricuspid regurgitation velocity","volume":"19","author":"Babu","year":"2025","journal-title":"Proteomics Clin Appl"},{"issue":"3","key":"2026052610365517300_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1021\/acs.jproteome.3c00748","article-title":"Nontargeted plasma proteomic analysis of renal disease and pulmonary hypertension in patients with sickle cell disease","volume":"23","author":"Garrett","year":"2024","journal-title":"J Proteome Res"},{"issue":"13","key":"2026052610365517300_bib29","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.3390\/ijms26136338","article-title":"The whole blood transcriptomic analysis in sickle cell disease reveals RUNX3 as a potential marker for vaso-occlusive crises","volume":"26","author":"Taha","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"23","key":"2026052610365517300_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"9","key":"2026052610365517300_bib31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2020005944","article-title":"IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias","volume":"137","author":"Gupta","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2026052610365517300_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cyto.2011.08.013","article-title":"Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome","volume":"56","author":"Cerqueira","year":"2011","journal-title":"Cytokine"},{"issue":"10","key":"2026052610365517300_bib33","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1016\/j.cell.2025.03.013","article-title":"Human proteome distribution atlas for tissue-specific plasma proteome dynamics","volume":"188","author":"Malmstrom","year":"2025","journal-title":"Cell"},{"issue":"3","key":"2026052610365517300_bib34","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"Plos Med"},{"issue":"6","key":"2026052610365517300_bib35","doi-asserted-by":"crossref","first-page":"e14136","DOI":"10.1111\/acel.14136","article-title":"Plasma proteomic signature of human longevity","volume":"23","author":"Liu","year":"2024","journal-title":"Aging Cell"},{"issue":"3","key":"2026052610365517300_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11010-023-04743-x","article-title":"GDF15 as a key disease target and biomarker: linking chronic lung diseases and ageing","volume":"479","author":"Wan","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"2026052610365517300_bib37","doi-asserted-by":"crossref","first-page":"116475","DOI":"10.1016\/j.biopha.2024.116475","article-title":"Growth and differentiation factor-15: a link between inflammaging and cardiovascular disease","volume":"174","author":"Nyarady","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026052610365517300_bib38","first-page":"1","article-title":"Growth differentiation factor 15 (GDF-15) in kidney diseases","volume":"114","author":"Delrue","year":"2023","journal-title":"Adv Clin Chem"},{"key":"2026052610365517300_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genom-083117-021320","article-title":"Sickle cell anemia and its phenotypes","volume":"19","author":"Williams","year":"2018","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"2026052610365517300_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajh.24134","article-title":"Critical reviews: how we treat sickle cell patients with leg ulcers","volume":"91","author":"Minniti","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"2026052610365517300_bib41","doi-asserted-by":"crossref","first-page":"e2453669","DOI":"10.1001\/jamanetworkopen.2024.53669","article-title":"Brain age modeling and cognitive outcomes in young adults with and without sickle cell anemia","volume":"8","author":"Ford","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026052610365517300_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2023011188","article-title":"Characterizing epigenetic aging in an adult sickle cell disease cohort","volume":"8","author":"Le","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"2026052610365517300_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.hoc.2022.06.006","article-title":"Genetic modifiers of sickle cell disease","volume":"36","author":"Pincez","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"2026052610365517300_bib44","doi-asserted-by":"crossref","first-page":"127060","DOI":"10.1016\/j.envpol.2025.127060","article-title":"Effects of short-term changes in ambient carbon monoxide on sickle cell disease hospital encounters","volume":"385","author":"Li","year":"2025","journal-title":"Environ Pollut"},{"issue":"8","key":"2026052610365517300_bib45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jpepsy\/jsaf031","article-title":"Airborne injustice: a preliminary exploration of the associations between pollutants and hospitalizations, sleep, and cognition in children and young adults living with sickle cell disease","volume":"50","author":"Hamdule","year":"2025","journal-title":"J Pediatr Psychol"},{"issue":"23","key":"2026052610365517300_bib46","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1182\/bloodadvances.2023012379","article-title":"Social determinants of health affect disease severity among preschool children with sickle cell disease","volume":"8","author":"Khan","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"2026052610365517300_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jpepsy\/jsaf028","article-title":"Stigma among youth with sickle cell disease in community and medical settings: a scoping review","volume":"50","author":"Abelson","year":"2025","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"2026052610365517300_bib48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2012.068965","article-title":"The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe","volume":"98","author":"Nouraie","year":"2013","journal-title":"Haematologica"},{"key":"2026052610365517300_bib49","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.27.25334571","article-title":"Proteomic prediction of disease largely reflects environmental risk exposure","author":"Tsuo","year":"29  2025","journal-title":"medRxiv"},{"key":"2026052610365517300_bib50","doi-asserted-by":"crossref","first-page":"100493","DOI":"10.1016\/j.conctc.2019.100493","article-title":"Biomarker-guided trials: challenges in practice","volume":"16","author":"Antoniou","year":"2019","journal-title":"Contemp Clin Trials Commun"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3420\/2519341\/blooda_adv-2025-019294-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3420\/2519341\/blooda_adv-2025-019294-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:37:11Z","timestamp":1779806231000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/10\/3420\/567290\/Plasma-proteome-signatures-are-predictive-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019294","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,14]]}}}